The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 24, 2012
Filed:
Aug. 12, 2009
Lee D. Arnold, Mt. Sinai, NY (US);
Cara Cesario, Mishawaka, IN (US);
Heather Coate, San Diego, CA (US);
Andrew Philip Crew, N. Babylon, NY (US);
Hanqing Dong, Syosset, NY (US);
Kenneth Foreman, Syosset, NY (US);
Ayako Honda, Quincy, MA (US);
Radoslaw Laufer, Ontario, CA;
An-hu LI, Commack, NY (US);
Kristen Michelle Mulvihill, E. Northport, NY (US);
Mark J. Mulvihill, E. Northport, NY (US);
Anthony I. Nigro, Westwood, NJ (US);
Bijoy Panicker, Holbrook, NY (US);
Amo G. Steinig, E. Northport, NY (US);
Yingchuan Sun, Arlington, MA (US);
Qinghua Weng, West Islip, NY (US);
Douglas S. Werner, Holtsville, NY (US);
Michael J. Wyle, Hempstead, NY (US);
Tao Zhang, Waltham, MA (US);
Lee D. Arnold, Mt. Sinai, NY (US);
Cara Cesario, Mishawaka, IN (US);
Heather Coate, San Diego, CA (US);
Andrew Philip Crew, N. Babylon, NY (US);
Hanqing Dong, Syosset, NY (US);
Kenneth Foreman, Syosset, NY (US);
Ayako Honda, Quincy, MA (US);
Radoslaw Laufer, Ontario, CA;
An-Hu Li, Commack, NY (US);
Kristen Michelle Mulvihill, E. Northport, NY (US);
Mark J. Mulvihill, E. Northport, NY (US);
Anthony I. Nigro, Westwood, NJ (US);
Bijoy Panicker, Holbrook, NY (US);
Amo G. Steinig, E. Northport, NY (US);
Yingchuan Sun, Arlington, MA (US);
Qinghua Weng, West Islip, NY (US);
Douglas S. Werner, Holtsville, NY (US);
Michael J. Wyle, Hempstead, NY (US);
Tao Zhang, Waltham, MA (US);
OSI Pharmaceuticals, LLC, Farmingdale, NY (US);
Abstract
Compounds of the formula and pharmaceutically acceptable salts thereof, wherein X, X, X, X, X, X, X, R, and Qare defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.